Portside Wealth Group, LLC

Position in ABBV — AbbVie Inc.

CIK 1978608 Provo, UT

Position in ABBV

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$4,457,047

+$646,189 QoQ

Shares Held

17,712

+1.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.78%

of 13F equity value

Holder Rank

#1,386

of 4,153 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Portside Wealth Group, LLC holds $35,072,554 across 13 Drug Manufacturers - General names. ABBV ranks #3 (12.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	28,497	$7,237,382
2	LLY	ELI LILLY & Co	5,720	$6,860,739
3	ABBV	AbbVie Inc. This page	17,712	$4,457,047
4	NVO	Novo Nordisk A S	76,258	$3,655,808
5	MRK	Merck & Co., Inc.	21,032	$2,702,612
6	PFE	Pfizer Inc	89,045	$2,144,203
7	GILD	Gilead Sciences, Inc.	15,449	$1,951,826
8	NVS	Novartis AG	12,409	$1,944,738

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,457,047	17,712	+1.1%	Shares	Other	2026-07-14
2026-03-31	$3,810,858	17,522	-1.5%	Shares	Sole	2026-05-12
2025-12-31	$4,063,008	17,782	-1.5%	Shares	Sole	2026-01-21
2025-09-30	$4,179,759	18,052	+0.3%	Shares	Other	2025-11-05
2025-06-30	$3,342,272	18,006	-0.6%	Shares	Sole	2025-08-11
2025-03-31	$3,796,292	18,119	+19.6%	Shares	Sole	2025-04-14
2024-12-31	$2,691,444	15,146	+1.9%	Shares	Other	2025-04-14
2024-09-30	$2,933,959	14,857	+0.5%	Shares	Other	2024-10-31
2024-06-30	$2,534,379	14,776	-3.3%	Shares	Other	2024-07-18
2024-03-31	$2,781,213	15,273	-9.2%	Shares	Other	2024-04-17
2023-12-31	$2,605,355	16,812	-3.3%	Shares	Other	2024-01-16
2023-09-30	$2,591,855	17,388	+3.5%	Shares	Other	2023-10-27
2023-06-30	$2,264,002	16,804	—	Shares	Other	2023-09-01
No filing history on record for this holder in this stock.